These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7739846)

  • 61. Comparison of immunohistochemical and biochemical assay of steroid receptors in primary breast cancer--clinical associations and reasons for discrepancies.
    Chebil G; Bendahl PO; Idvall I; Fernö M
    Acta Oncol; 2003; 42(7):719-25. PubMed ID: 14690157
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estrogen and progesterone receptors status in the prediction of response of breast cancer to endocrine therapy (preliminary report).
    Nardelli GB; Lamaina V; Siliotti F
    Eur J Gynaecol Oncol; 1986; 7(3):151-8. PubMed ID: 3536517
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors.
    Nagasue N; Kohno H; Yamanoi A; Kimoto T; Chang YC; Nakamura T
    Cancer; 1991 May; 67(10):2501-5. PubMed ID: 1849788
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hormone receptors and Japanese breast cancer.
    Matsumoto K; Kitamura Y; Sugano H
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estrogen and progesterone receptors in gastric cancer.
    Tokunaga A; Nishi K; Matsukura N; Tanaka N; Onda M; Shirota A; Asano G; Hayashi K
    Cancer; 1986 Apr; 57(7):1376-9. PubMed ID: 3948119
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases.
    Zafrani B; Aubriot MH; Mouret E; De Crémoux P; De Rycke Y; Nicolas A; Boudou E; Vincent-Salomon A; Magdelénat H; Sastre-Garau X
    Histopathology; 2000 Dec; 37(6):536-45. PubMed ID: 11122436
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Receptor levels in breast cancer.
    Nardelli GB; Lamaina V; Marson S; Miola G
    Eur J Gynaecol Oncol; 1988; 9(1):54-8. PubMed ID: 3345786
    [TBL] [Abstract][Full Text] [Related]  

  • 69. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).
    Hammond ME; Hayes DF; Dowsett M; Allred DC; Hagerty KL; Badve S; Fitzgibbons PL; Francis G; Goldstein NS; Hayes M; Hicks DG; Lester S; Love R; Mangu PB; McShane L; Miller K; Osborne CK; Paik S; Perlmutter J; Rhodes A; Sasano H; Schwartz JN; Sweep FC; Taube S; Torlakovic EE; Valenstein P; Viale G; Visscher D; Wheeler T; Williams RB; Wittliff JL; Wolff AC; ;
    Arch Pathol Lab Med; 2010 Jul; 134(7):e48-72. PubMed ID: 20586616
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].
    Jacquemier J; Boudaoura T; Martin PM; Torrente M; Hassoun J
    Ann Pathol; 1991; 11(4):224-30. PubMed ID: 1958256
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Demonstration of estrogen and progesterone receptors in breast cancers with monoclonal antibodies. Different results with enzyme-immunoassay and immunohistochemical methods.
    Mink D; Hollaender M; von Tongelen B; Villena-Heinsen C; Schmidt W
    Eur J Gynaecol Oncol; 1995; 16(2):81-91. PubMed ID: 7641743
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer.
    Nishimura R; Misumi A; Kimura M; Tokunaga T; Akagi M
    Jpn J Surg; 1982; 12(3):191-7. PubMed ID: 6290728
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
    Baker VA; Puddefoot JR; Marsigliante S; Barker S; Goode AW; Vinson GP
    Br J Cancer; 1992 Dec; 66(6):1083-7. PubMed ID: 1457348
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation.
    Andersen J; Bentzen SM; Poulsen HS
    Eur J Cancer Clin Oncol; 1988 Mar; 24(3):377-84. PubMed ID: 3289941
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group.
    Fernö M; Borg A; Johansson U; Norgren A; Olsson H; Rydén S; Sellberg G
    Acta Oncol; 1990; 29(2):129-35. PubMed ID: 2334566
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
    Ciocca DR; Puy LA; Fasoli LC
    Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytological evaluation of biological prognostic markers from primary breast carcinomas.
    Makris A; Allred DC; Powles TJ; Dowsett M; Fernando IN; Trott PA; Ashley SE; Ormerod MG; Titley JC; Osborne CK
    Breast Cancer Res Treat; 1997 May; 44(1):65-74. PubMed ID: 9164679
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on Hormone Receptors and Prognosis in Breast Cancer.
    Nomura Y; Miura S; Koyama H; Enomoto K; Kasumi F; Yamamoto H; Kimura M; Tominaga T; Iino H; Morimoto T
    Cancer; 1992 Jan; 69(1):153-64. PubMed ID: 1727658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.